nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Pindolol—Anxiety—Cisplatin—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Pindolol—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Pindolol—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Pindolol—Hot flush—Doxorubicin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Pindolol—Tachycardia—Fluorouracil—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Pindolol—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Pindolol—Vertigo—Etoposide—urinary bladder cancer	0.00243	0.00243	CcSEcCtD
Pindolol—Abdominal pain—Thiotepa—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Pindolol—Hypotension—Gemcitabine—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Pindolol—Oedema—Cisplatin—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Pindolol—Cardiac failure—Doxorubicin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Pindolol—Loss of consciousness—Etoposide—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Pindolol—Lethargy—Doxorubicin—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Pindolol—Hypotension—Fluorouracil—urinary bladder cancer	0.00237	0.00237	CcSEcCtD
Pindolol—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Pindolol—Tachycardia—Cisplatin—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Pindolol—Insomnia—Gemcitabine—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Pindolol—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Pindolol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Pindolol—Dyspnoea—Gemcitabine—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Pindolol—Chest pain—Etoposide—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Pindolol—Orthostatic hypotension—Epirubicin—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Pindolol—Insomnia—Fluorouracil—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Pindolol—Somnolence—Gemcitabine—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Pindolol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Pindolol—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Pindolol—Somnolence—Fluorouracil—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Pindolol—Hypotension—Cisplatin—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Pindolol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Pindolol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Pindolol—Fatigue—Gemcitabine—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Pindolol—Confusional state—Etoposide—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Pindolol—Pain—Gemcitabine—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Pindolol—Constipation—Gemcitabine—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Pindolol—Asthenia—Thiotepa—urinary bladder cancer	0.0022	0.0022	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Pindolol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Pindolol—Pruritus—Thiotepa—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Pindolol—Pain—Fluorouracil—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Pindolol—Paraesthesia—Cisplatin—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Pindolol—Tachycardia—Etoposide—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Pindolol—Dyspnoea—Cisplatin—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Pindolol—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Pindolol—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Pindolol—Orthostatic hypotension—Doxorubicin—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Pindolol—Diarrhoea—Thiotepa—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Pindolol—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Pindolol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Pindolol—Depression—Methotrexate—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Pindolol—Hypotension—Etoposide—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Pindolol—Pain—Cisplatin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Pindolol—Dizziness—Thiotepa—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Pindolol—Pollakiuria—Epirubicin—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Pindolol—Sweating—Methotrexate—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Pindolol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Pindolol—Paraesthesia—Etoposide—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Pindolol—Weight increased—Epirubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Pindolol—Dyspnoea—Etoposide—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Pindolol—Somnolence—Etoposide—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Pindolol—Vomiting—Thiotepa—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Pindolol—Drowsiness—Epirubicin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Pindolol—Rash—Thiotepa—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Pindolol—Dermatitis—Thiotepa—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Pindolol—Headache—Thiotepa—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Pindolol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Pindolol—Fatigue—Etoposide—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Pindolol—Pain—Etoposide—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Pindolol—Constipation—Etoposide—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Pindolol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Pindolol—Sweating—Epirubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Pindolol—Pollakiuria—Doxorubicin—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Pindolol—Asthenia—Gemcitabine—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Pindolol—Weight increased—Doxorubicin—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Pindolol—Pruritus—Gemcitabine—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Pindolol—Nausea—Thiotepa—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Pindolol—Feeling abnormal—Etoposide—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Pindolol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Pindolol—Pruritus—Fluorouracil—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Pindolol—Drowsiness—Doxorubicin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Pindolol—Bradycardia—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Pindolol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Pindolol—Abdominal pain—Etoposide—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Pindolol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Pindolol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Pindolol—Asthenia—Cisplatin—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Pindolol—Sweating—Doxorubicin—urinary bladder cancer	0.00172	0.00172	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Pindolol—Dizziness—Fluorouracil—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Pindolol—Visual impairment—Epirubicin—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Pindolol—Diarrhoea—Cisplatin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Pindolol—Vomiting—Gemcitabine—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Bradycardia—Doxorubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Pindolol—Rash—Gemcitabine—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Pindolol—Dermatitis—Gemcitabine—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Pindolol—Tinnitus—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Pindolol—Headache—Gemcitabine—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Pindolol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Pindolol—Vomiting—Fluorouracil—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Pindolol—Rash—Fluorouracil—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Pindolol—Dermatitis—Fluorouracil—urinary bladder cancer	0.0016	0.0016	CcSEcCtD
Pindolol—Headache—Fluorouracil—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Pindolol—Asthenia—Etoposide—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Pindolol—Angiopathy—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Pindolol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Pindolol—Pruritus—Etoposide—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Pindolol—Visual impairment—Doxorubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Pindolol—Nausea—Gemcitabine—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Pindolol—Vomiting—Cisplatin—urinary bladder cancer	0.00153	0.00153	CcSEcCtD
Pindolol—Mental disorder—Epirubicin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Pindolol—Rash—Cisplatin—urinary bladder cancer	0.00152	0.00152	CcSEcCtD
Pindolol—Dermatitis—Cisplatin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Diarrhoea—Etoposide—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Nausea—Fluorouracil—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Pindolol—Tinnitus—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Pindolol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Pindolol—Flatulence—Epirubicin—urinary bladder cancer	0.00149	0.00149	CcSEcCtD
Pindolol—Tension—Epirubicin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Pindolol—Nervousness—Epirubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Pindolol—Angiopathy—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Pindolol—Dizziness—Etoposide—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Pindolol—Muscle spasms—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Pindolol—Vertigo—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Pindolol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Pindolol—Nausea—Cisplatin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Pindolol—Mental disorder—Doxorubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Pindolol—Vomiting—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Pindolol—Rash—Etoposide—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Pindolol—Dermatitis—Etoposide—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Pindolol—Headache—Etoposide—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Flatulence—Doxorubicin—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Chest pain—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Myalgia—Methotrexate—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Pindolol—Tension—Doxorubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Pindolol—Nervousness—Doxorubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Pindolol—Vertigo—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Pindolol—Syncope—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Pindolol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Pindolol—Palpitations—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Pindolol—Confusional state—Methotrexate—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Pindolol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Pindolol—Nausea—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Arthralgia—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Chest pain—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Myalgia—Epirubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Pindolol—Anxiety—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Pindolol—Dry mouth—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Pindolol—Vertigo—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Pindolol—Syncope—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Pindolol—Confusional state—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Pindolol—Palpitations—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Pindolol—Oedema—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Pindolol—Hypotension—Methotrexate—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Pindolol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Pindolol—Shock—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Pindolol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Pindolol—Tachycardia—Epirubicin—urinary bladder cancer	0.00121	0.00121	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Pindolol—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Insomnia—Methotrexate—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Myalgia—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Arthralgia—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Chest pain—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Anxiety—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Pindolol—Somnolence—Methotrexate—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Pindolol—Dry mouth—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Pindolol—Hypotension—Epirubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Pindolol—Confusional state—Doxorubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Pindolol—Oedema—Doxorubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Pindolol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Pindolol—Fatigue—Methotrexate—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Pindolol—Pain—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Pindolol—Shock—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Pindolol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Pindolol—Insomnia—Epirubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Pindolol—Tachycardia—Doxorubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Pindolol—Paraesthesia—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Pindolol—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Pindolol—Dyspnoea—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Pindolol—Somnolence—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Pindolol—Dyspepsia—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Pindolol—Hypotension—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Pindolol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Pindolol—Fatigue—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Pindolol—Pain—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Pindolol—Constipation—Epirubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Pindolol—Insomnia—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Pindolol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Pindolol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Pindolol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Pindolol—Somnolence—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Pindolol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Pindolol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Pindolol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000987	0.000987	CcSEcCtD
Pindolol—Fatigue—Doxorubicin—urinary bladder cancer	0.000985	0.000985	CcSEcCtD
Pindolol—Pain—Doxorubicin—urinary bladder cancer	0.000977	0.000977	CcSEcCtD
Pindolol—Constipation—Doxorubicin—urinary bladder cancer	0.000977	0.000977	CcSEcCtD
Pindolol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000976	0.000976	CcSEcCtD
Pindolol—Asthenia—Methotrexate—urinary bladder cancer	0.000947	0.000947	CcSEcCtD
Pindolol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000942	0.000942	CcSEcCtD
Pindolol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000934	0.000934	CcSEcCtD
Pindolol—Pruritus—Methotrexate—urinary bladder cancer	0.000934	0.000934	CcSEcCtD
Pindolol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000903	0.000903	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000903	0.000903	CcSEcCtD
Pindolol—Asthenia—Epirubicin—urinary bladder cancer	0.000886	0.000886	CcSEcCtD
Pindolol—Pruritus—Epirubicin—urinary bladder cancer	0.000874	0.000874	CcSEcCtD
Pindolol—Dizziness—Methotrexate—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Pindolol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000845	0.000845	CcSEcCtD
Pindolol—Vomiting—Methotrexate—urinary bladder cancer	0.000839	0.000839	CcSEcCtD
Pindolol—Rash—Methotrexate—urinary bladder cancer	0.000832	0.000832	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—urinary bladder cancer	0.000831	0.000831	CcSEcCtD
Pindolol—Headache—Methotrexate—urinary bladder cancer	0.000827	0.000827	CcSEcCtD
Pindolol—Asthenia—Doxorubicin—urinary bladder cancer	0.00082	0.00082	CcSEcCtD
Pindolol—Dizziness—Epirubicin—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Pindolol—Pruritus—Doxorubicin—urinary bladder cancer	0.000808	0.000808	CcSEcCtD
Pindolol—Vomiting—Epirubicin—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Pindolol—Nausea—Methotrexate—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Pindolol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000782	0.000782	CcSEcCtD
Pindolol—Rash—Epirubicin—urinary bladder cancer	0.000779	0.000779	CcSEcCtD
Pindolol—Dermatitis—Epirubicin—urinary bladder cancer	0.000778	0.000778	CcSEcCtD
Pindolol—Headache—Epirubicin—urinary bladder cancer	0.000774	0.000774	CcSEcCtD
Pindolol—Dizziness—Doxorubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Pindolol—Nausea—Epirubicin—urinary bladder cancer	0.000734	0.000734	CcSEcCtD
Pindolol—Vomiting—Doxorubicin—urinary bladder cancer	0.000727	0.000727	CcSEcCtD
Pindolol—Rash—Doxorubicin—urinary bladder cancer	0.00072	0.00072	CcSEcCtD
Pindolol—Dermatitis—Doxorubicin—urinary bladder cancer	0.00072	0.00072	CcSEcCtD
Pindolol—Headache—Doxorubicin—urinary bladder cancer	0.000716	0.000716	CcSEcCtD
Pindolol—Nausea—Doxorubicin—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
